Connection

AGDA KARINA B. ETEROVIC to Imatinib Mesylate

This is a "connection" page, showing publications AGDA KARINA B. ETEROVIC has written about Imatinib Mesylate.
Connection Strength

0.029
  1. Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma. J Invest Dermatol. 2019 03; 139(3):728-731.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.